List of IPO Filings
Annovis Bio, Inc.
View detailsFiling Date: February 5, 2025
Accession Number: 000110465925009279
Corporate Action: Ipo
Summary preview: On February 3, 2025, Annovis Bio, Inc. entered into an Underwriting Agreement with ThinkEquity LLC f...
CERO THERAPEUTICS HOLDINGS, INC.
View detailsFiling Date: February 5, 2025
Accession Number: 000121390025010230
Corporate Action: Ipo
Summary preview: Cero Therapeutics Holdings, Inc. filed an amendment to their registration statement on Form S-1 as p...
Filing Date: January 31, 2025
Accession Number: 000121390025008639
Corporate Action: Ipo
Summary preview: CERO Therapeutics Holdings, Inc. has submitted a request for the acceleration of the effective date ...
Filing Date: January 21, 2025
Accession Number: 000121390025004742
Corporate Action: Ipo
Summary preview: Cero Therapeutics Holdings, Inc. is amending their Form S-1 to register for an initial public offeri...
Filing Date: December 23, 2024
Accession Number: 000121390024111475
Corporate Action: Ipo
Summary preview: Cero Therapeutics Holdings, Inc. filed a Registration Statement under the Securities Act of 1933 on ...
DIH HOLDING US, INC.
View detailsFiling Date: February 5, 2025
Accession Number: 000149315225004925
Corporate Action: Ipo
Summary preview: On January 31, 2025, DIH Holding US, Inc. announced a best-efforts public offering consisting of 5,9...
Filing Date: February 3, 2025
Accession Number: 000149315225004696
Corporate Action: Ipo
Summary preview: On February 3, 2025, DIH HOLDING US, INC. announced the pricing and closing of a best-efforts public...
Filing Date: February 3, 2025
Accession Number: 000149315225004604
Corporate Action: Ipo
Summary preview: DIH HOLDING US, INC. is offering 5,937,100 units, each consisting of one share of Class A Common Sto...
Filing Date: January 10, 2025
Accession Number: 000149315225001634
Corporate Action: Ipo
Summary preview: DIH Holding US, Inc. has filed a correspondence with the U.S. Securities and Exchange Commission to ...
Filing Date: January 8, 2025
Accession Number: 000149315225001419
Corporate Action: Ipo
Summary preview: DIH HOLDING US, INC. filed Amendment No. 1 to its Form S-1 registration statement under the Securiti...
Eastside Distilling, Inc.
View detailsFiling Date: February 5, 2025
Accession Number: 000149315225005053
Corporate Action: Ipo
Summary preview: Eastside Distilling, Inc., registered under the dba Beeline Holdings, has filed a Form S-3 registrat...
Filing Date: January 8, 2025
Accession Number: 000149315225001415
Corporate Action: Ipo
Summary preview: This Form S-1/A filing represents an amendment to the registration statement initially filed for Eas...
Filing Date: January 3, 2025
Accession Number: 000149315225000284
Corporate Action: Ipo
Summary preview: Eastside Distilling, Inc. filed an S-1/A form on January 3, 2025, highlighting its updated registrat...
EMBRAER S.A.
View detailsFiling Date: February 5, 2025
Accession Number: 000119312525020507
Corporate Action: Ipo
Summary preview: On February 5, 2025, Embraer S.A. filed a registration statement under the Securities Act of 1933 on...
Falcon's Beyond Global, Inc.
View detailsFiling Date: February 5, 2025
Accession Number: 000121390025010279
Corporate Action: Ipo
Summary preview: Falcon’s Beyond Global, Inc. filed Amendment No. 3 to its Form S-1 registration statement with the S...
Filing Date: February 5, 2025
Accession Number: 000121390025010499
Corporate Action: Ipo
Summary preview: On February 5, 2025, Falcon's Beyond Global, Inc. filed its fourth amendment to the Form S-1 registr...
Filing Date: January 21, 2025
Accession Number: 000121390025005073
Corporate Action: Ipo
Summary preview: Falcon’s Beyond Global, Inc. filed Amendment No. 2 to Form S-1 Registration Statement with the SEC, ...
Filing Date: January 10, 2025
Accession Number: 000121390025002300
Corporate Action: Ipo
Summary preview: Falcon’s Beyond Global, Inc. is filing an amendment to its registration statement on Form S-1 with t...
FG Merger II Corp.
View detailsFiling Date: February 5, 2025
Accession Number: 000110465925009685
Corporate Action: Ipo
Summary preview: On January 30, 2025, FG Merger II Corp. consummated its initial public offering (IPO) of 8,000,000 u...
Filing Date: February 3, 2025
Accession Number: 000110465925008720
Corporate Action: Ipo
Summary preview: FG Merger II Corp. has filed Form 8-K to report the consummation of its initial public offering (IPO...
Filing Date: January 21, 2025
Accession Number: 000110465925004764
Corporate Action: Ipo
Summary preview: FG Merger II Corp. is presenting a preliminary prospectus for its initial public offering (IPO) invo...
Filing Date: December 10, 2024
Accession Number: 000110465924127396
Corporate Action: Ipo
Summary preview: FG Merger II Corp. has filed Amendment No. 3 to its Registration Statement on Form S-1 in response t...
Filing Date: November 27, 2023
Accession Number: 000110465923121206
Corporate Action: Ipo
Summary preview: FG Merger II Corp. submitted a response to comments from the SEC regarding their Registration Statem...
GH Research PLC
View detailsFiling Date: February 5, 2025
Accession Number: 000114036125003183
Corporate Action: Ipo
Summary preview: GH Research PLC is offering 10,000,000 ordinary shares at a public offering price of $15.00 each, to...
Filing Date: February 3, 2025
Accession Number: 000114036125002892
Corporate Action: Ipo
Summary preview: GH Research PLC is offering $150 million of ordinary shares with a nominal value of $0.025 per share...
Glucotrack, Inc.
View detailsFiling Date: February 5, 2025
Accession Number: 000149315225004955
Corporate Action: Ipo
Summary preview: Glucotrack, Inc. is conducting a registered direct offering of 2,638,042 shares of its common stock ...
Apollo Infrastructure Co LLC
View detailsFiling Date: February 4, 2025
Accession Number: 000095017025013082
Corporate Action: Ipo
Summary preview: On January 30, 2025, Apollo Infrastructure Company LLC issued and sold unregistered shares to third-...
BriaCell Therapeutics Corp.
View detailsFiling Date: February 4, 2025
Accession Number: 000149315225004856
Corporate Action: Ipo
Summary preview: BriaCell Therapeutics Corp. is offering 762,500 common shares at an offering price of $4.00 per shar...
Filing Date: February 3, 2025
Accession Number: 000149315225004684
Corporate Action: Ipo
Summary preview: BriaCell Therapeutics Corp. is offering common shares at an offering price of $ per share through a ...
Cellectar Biosciences, Inc.
View detailsFiling Date: February 4, 2025
Accession Number: 000110465925009108
Corporate Action: Ipo
Summary preview: Cellectar Biosciences, Inc. has requested the Securities and Exchange Commission to accelerate the e...
Filing Date: January 29, 2025
Accession Number: 000141057825000060
Corporate Action: Ipo
Summary preview: Cellectar Biosciences, Inc. filed a Form S-1 registration statement with the SEC on January 29, 2025...
Luokung Technology Corp.
View detailsFiling Date: February 4, 2025
Accession Number: 000121390025009931
Corporate Action: Ipo
Summary preview: Luokung Technology Corp. is requesting the acceleration of the effectiveness of its Registration Sta...
Filing Date: January 31, 2025
Accession Number: 000121390025008891
Corporate Action: Ipo
Summary preview: On January 31, 2025, Luokung Technology Corp. filed an amendment to its Form F-1 registration statem...
Filing Date: January 22, 2025
Accession Number: 000121390025005608
Corporate Action: Ipo
Summary preview: Luokung Technology Corp filed a registration statement for the proposed sale of up to 3,850,792 ordi...
MSC INCOME FUND, INC.
View detailsFiling Date: February 4, 2025
Accession Number: 000153577825000053
Corporate Action: Ipo
Summary preview: On January 29, 2025, MSC Income Fund, Inc. entered into a New Investment Advisory Agreement with MSC...
Filing Date: January 30, 2025
Accession Number: 000153577825000050
Corporate Action: Ipo
Summary preview: MSC Income Fund, Inc. is conducting a public offering of 5,500,000 shares of common stock at a publi...
Filing Date: January 28, 2025
Accession Number: 000153577825000041
Corporate Action: Ipo
Summary preview: On January 28, 2025, MSC Income Fund, Inc. announced the pricing of its public offering through a pr...
Nuveen Churchill Private Capital Income Fund
View detailsFiling Date: February 4, 2025
Accession Number: 000162828025003535
Corporate Action: Ipo
Summary preview: Nuveen Churchill Private Capital Income Fund registers $500,000,000 in additional common shares of b...
Yoshiharu Global Co.
View detailsFiling Date: February 4, 2025
Accession Number: 000149315225004833
Corporate Action: Ipo
Summary preview: Yoshiharu Global Co. has filed a Form S-1 registration statement with the SEC, indicating its intent...
Dragonfly Energy Holdings Corp.
View detailsFiling Date: February 3, 2025
Accession Number: 000149315225004680
Corporate Action: Ipo
Summary preview: Dragonfly Energy Holdings Corp. has filed a registration statement under the Securities Act of 1933 ...
Enveric Biosciences, Inc.
View detailsFiling Date: February 3, 2025
Accession Number: 000149315225004528
Corporate Action: Ipo
Summary preview: Enveric Biosciences, Inc. is filing for an initial public offering (IPO) of its series CRedeemable P...
Filing Date: January 30, 2025
Accession Number: 000149315225004214
Corporate Action: Ipo
Summary preview: Enveric Biosciences, Inc. submitted a request to the SEC for the acceleration of the effectiveness o...
Filing Date: January 30, 2025
Accession Number: 000149315225004213
Corporate Action: Ipo
Summary preview: Enveric Biosciences, Inc. filed an amended S-1 registration statement with the SEC for its initial p...
Filing Date: January 30, 2025
Accession Number: 000149315225004292
Corporate Action: Ipo
Summary preview: This document is Amendment No. 2 to the Form S-1 Registration Statement of Enveric Biosciences, Inc....
Filing Date: January 14, 2025
Accession Number: 000149315225002214
Corporate Action: Ipo
Summary preview: Enveric Biosciences, Inc. filed an S-1 registration statement in connection with its initial public ...
FibroBiologics, Inc.
View detailsFiling Date: February 3, 2025
Accession Number: 000149315225004623
Corporate Action: Ipo
Summary preview: FibroBiologics, Inc. has filed a Form S-3 registration statement with the SEC on February 3, 2025, t...
Filing Date: January 14, 2025
Accession Number: 000149315225002162
Corporate Action: Ipo
Summary preview: FibroBiologics, Inc. is conducting an initial public offering for the resale of up to 41,489,581 sha...
Filing Date: January 10, 2025
Accession Number: 000149315225001797
Corporate Action: Ipo
Summary preview: FibroBiologics, Inc. has submitted a request to the Securities and Exchange Commission to accelerate...
Filing Date: January 10, 2025
Accession Number: 000149315225001793
Corporate Action: Ipo
Summary preview: On January 10, 2025, FibroBiologics, Inc. filed an amendment to its registration statement on Form S...
Filing Date: December 30, 2024
Accession Number: 000149315224052400
Corporate Action: Ipo
Summary preview: FibroBiologics, Inc. filed a registration statement for the resale of up to 41,289,033 shares of its...